References

Microfluidics: the fur-free way towards personalised medicine in cancer therapy.

2016 · External reference

Interconnected Microphysiological Systems for Quantitative Biology and Pharmacology Studies.

10.1038/s41598-018-22749-0 · 2018 · External reference

Organs-on-a-chip engineering.

10.1016/b978-0-12-817202-5.00003-6 · 2020 · External reference

Biology-inspired microphysiological system approaches to solve the prediction dilemma of substance testing.

10.14573/altex.1603161 · 2016 · External reference

First EMA workshop on non-animal approaches in support of medicinal product development: challenges and opportunities for use of micro-physiological systems.

2017 · External reference

Non-Animal Approaches the Way Forward.

10.2779/373944 · 2016 · External reference

Statement by FDA Commissioner Scott Gottlieb, M.D., on efforts to reduce animal testing through a study aimed at eliminating the use of dogs in certain trials.

External reference

Administrator Wheeler Signs Memo to Reduce Animal Testing, Awards $4.25 Million to Advance Research on Alternative Methods to Animal Testing.

External reference

Impact of organ-on-a-chip technology on pharmaceutical R&D costs.

10.1016/j.drudis.2019.06.003 · 2019 · External reference

The Emergence of Microphysiological Systems (Organs-on-chips) as Paradigm-changing Tools for Toxicologic Pathology.

10.1177/0192623318809065 · 2019 · External reference

Organ-on-chip Market Expected to reach $170 Million, Globally, by 2023.

External reference

Organ-on-Chip Market 2019 - Industry Analysis, Size, Share, Strategies and Forecast to 2023.

External reference

Organ-on-chip Market by Type (Heart-on-chip, Human-on-chip, Intestine-on-chip, Kidney-on-chip, Liver-on-chip, and Lung-on-chip) - Global Opportunity Analysis and Industry Forecast, 2017-2023.

External reference

Organ-on-Chip Market by Offering (Services, Products), by Type (Liver-on-Chip, Lung-on-Chip, Kidney-on-Chip, Heart-on-Chip, Intestine-on-Chip, Brain-on-Chip), by Application (Toxicology Research, Physiological Model Development, Drug Discovery), by End User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes), by Geography (U.S., Canada, Germany, U.K., France, China, Japan) – Global Market Size, Share, Development, Growth and Demand Forecast, 2016–2025.

External reference

Microfluidics Market Size, Share & Trends Analysis Report By Application (Lab-on-a-Chip, Organs-on-Chips, Continuous Flow), By Technology (Medical, Non-Medical), By Material, And Segment Forecasts, 2020 - 2027.

External reference

Microfluidics Market by Product (Devices, Components (Chips, Sensors, Pump, Valves, and Needles), Application (IVD [POC, Clinical, Veterinary], Research, Manufacturing, Therapeutics), End User and Region - Global Forecast to 2025.

External reference

Microfluidics Market - Growth, Trends, and Forecasts (2020 - 2025).

External reference

An introduction to drug disposition: The basic principles of absorption, distribution, metabolism, and excretion.

10.1177/019262339502300202 · 1995 · External reference

Evidence-based absorption, distribution, metabolism, excretion (ADME) and its interplay with alternative toxicity methods.

10.14573/altex.1610101 · 2016 · External reference

FDA's Woodcock: The Clinical Trials System is 'Broken'.

External reference

FDA's Woodcock: 'The clinical trial system is broken'.

External reference

Estimation of clinical trial success rates and related parameters.

10.1093/biostatistics/kxx069 · 2019 · External reference

The cost of drug development.

10.1056/nejmc1504317 · 2015 · External reference

A Tough Road: Cost To Develop One New Drug Is $2.6 Billion; Approval Rate for Drugs Entering Clinical Development is Less Than 12%.

External reference

Getting A Handle On Clinical Trial Costs.

External reference

How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned from European Countries.

10.1007/s40258-016-0300-z · 2017 · External reference

The cost of pharmaceutical innovation to patients.

10.1517/17460441.2.11.1431 · 2007 · External reference

Create a translational medicine knowledge repository--Research downsizing, mergers and increased outsourcing have reduced the depth of in-house translational medicine expertise and institutional memory at many pharmaceutical and biotech companies: How will they avoid relearning old lessons?

10.1186/1479-5876-9-56 · 2011 · External reference

Outsourcing Clinical Trials Outside of the US.

External reference

Partnering with the right CRO is a winning strategy for companies big and small.

External reference

Pharma is shuffling around jobs, but a skills gap threatens the process.

External reference

MImETIC INDiRECT-ED001.

2021 · External reference

Henrietta Lacks, HeLa cells, and cell culture contamination.

10.5858/133.9.1463 · 2009 · External reference

Validation of Alternative In Vitro Methods to Animal Testing: Concepts, Challenges, Processes and Tools.

10.1007/978-3-319-33826-2_4 · 2016 · External reference

Organ-on-Chip In Development: Towards a European roadmap for Organ-on-Chip.

2018 · External reference

Diffusion of innovations theory, principles, and practice.

10.1377/hlthaff.2017.1104 · 2018 · External reference

Horizon 2020 Work Programme 2014-2015 General Annexes.

External reference

Measuring Technology Readiness for Investment: Accelerating Technology Development and Improving Innovation Performance

2017 · External reference

An Approach for Developing Concept of Innovation Readiness Levels.

2011 · External reference

A Survey of Technology Readiness Level Users.

10.1002/j.2334-5837.2016.00283.x · 2016 · External reference

An Analysis of TRL-Based Cost and Schedule Models.

2012 · External reference

Addressing Patient Specificity in the Engineering of Tumor Models.

10.3389/fbioe.2019.00217 · 2019 · External reference

Modeling Patient-Derived Glioblastoma with Cerebral Organoids.

10.1016/j.celrep.2019.02.063 · 2019 · External reference

A novel spheroid-based co-culture model mimics loss of keratinocyte differentiation, melanoma cell invasion, and drug-induced selection of ABCB5-expressing cells.

10.1186/s12885-019-5606-4 · 2019 · External reference

CAAP48, a New Sepsis Biomarker, Induces Hepatic Dysfunction in an in vitro Liver-on-Chip Model.

10.3389/fimmu.2019.00273 · 2019 · External reference

3D Primary Hepatocyte Culture Systems for Analyses of Liver Diseases, Drug Metabolism, and Toxicity: Emerging Culture Paradigms and Applications.

10.1002/biot.201800347 · 2019 · External reference

Experimental study of tuberculosis: From animal models to complex cell systems and organoids.

10.1371/journal.ppat.1006421 · 2017 · External reference

Integrated gut/liver microphysiological systems elucidates inflammatory inter-tissue crosstalk.

10.1002/bit.26370 · 2017 · External reference

An alternative approach based on microfluidics to study drug metabolism and toxicity using liver and intestinal tissue [dissertation].

2010 · External reference

WAT-on-a-chip integrating human mature white adipocytes for mechanistic research and pharmaceutical applications.

10.1038/s41598-020-63710-4 · 2020 · External reference

A microfluidic chip based model for the study of full thickness human intestinal tissue using dual flow.

10.1063/1.4964813 · 2016 · External reference

A four-organ-chip for interconnected long-term co-culture of human intestine, liver, skin and kidney equivalents.

10.1039/c5lc00392j · 2015 · External reference

3D bioactive composite scaffolds for bone tissue engineering.

10.1016/j.bioactmat.2017.10.001 · 2017 · External reference

Bioinks and bioprinting technologies to make heterogeneous and biomimetic tissue constructs.

10.1016/j.mtbio.2019.100008 · 2019 · External reference

Hydrogels for liver tissue engineering.

10.3390/bioengineering6030059 · 2019 · External reference

Coaxial 3D bioprinting of self-assembled multicellular heterogeneous tumor fibers.

10.1038/s41598-017-01581-y · 2017 · External reference

Bioprinted 3D primary liver tissues allow assessment of organ-level response to clinical drug induced toxicity in vitro.

10.1371/journal.pone.0158674 · 2016 · External reference

Scaffold-Based or Scaffold-Free Bioprinting: Competing or Complementing Approaches?

10.1115/1.4030414 · 2015 · External reference

Advances in Hydrogels in Organoids and Organs-on-a-Chip.

10.1002/adma.201902042 · 2019 · External reference

Modular, tissue-specific, and biodegradable hydrogel cross-linkers for tissue engineering.

10.1126/sciadv.aaw7396 · 2019 · External reference

Functionalizing bioinks for 3D bioprinting applications.

10.1016/j.drudis.2018.09.012 · 2019 · External reference

Microfluidic bioprinting for engineering vascularized tissues and organoids.

10.3791/55957 · 2017 · External reference

Three-dimensional microfluidic model for tumor cell intravasation and endothelial barrier function.

10.1073/pnas.1210182109 · 2012 · External reference

Human organ culture: Updating the approach to bridge the gap from in vitro to in vivo in inflammation, cancer, and stem cell biology.

10.3389/fmed.2017.00148 · 2017 · External reference

Three-Dimensional Organoids in Cancer Research: The Search for the Holy Grail of Preclinical Cancer Modeling.

10.1089/omi.2018.0172 · 2018 · External reference

A simple high-throughput approach identifies actionable drug sensitivities in patient-derived tumor organoids.

10.1038/s42003-019-0305-x · 2019 · External reference

Comparison of cancer cells in 2D vs 3D culture reveals differences in AKT-mTOR-S6K signaling and drug responses.

10.1242/jcs.188102 · 2017 · External reference

Chemoresistance of Lung Cancer Cells: 2D and 3D In Vitro Models for Anticancer Drug Screening

10.5772/intechopen.78946 · 2018 · External reference

Human tissue models in cancer research: Looking beyond the mouse.

10.1242/dmm.031260 · 2017 · External reference

Enhancing reproducibility in cancer drug screening: How do we move forward?

10.1158/0008-5472.can-14-0725 · 2014 · External reference

Preclinical experimental models of drug metabolism and disposition in drug discovery and development.

10.1016/j.apsb.2012.10.004 · 2012 · External reference

Organoids provide an important window on inflammation in cancer.

10.3390/cancers10050151 · 2018 · External reference

Development of a primary human Small Intestine-on-a-Chip using biopsy-derived organoids.

10.1038/s41598-018-21201-7 · 2018 · External reference

Towards personalized computational oncology: From spatial models of tumour spheroids, to organoids, to tissues.

10.1098/rsif.2017.0703 · 2018 · External reference

Canine liver organoids for disease modeling of copper toxicosis and transplantation [master’s thesis].

2015 · External reference

A Living Biobank of Breast Cancer Organoids Captures Disease Heterogeneity.

10.1016/j.cell.2017.11.010 · 2018 · External reference

Organoids as Reliable Breast Cancer Study Models: An Update.

10.23937/ijor-2017/1710008 · 2018 · External reference

Ex vivo tumor culture systems for functional drug testing and therapy response prediction.

10.4155/fsoa-2017-0003 · 2017 · External reference

Tumor slice culture system to assess drug response of primary breast cancer.

10.1186/s12885-016-2119-2 · 2016 · External reference

Mouse models of metastasis: Progress and prospects.

10.1242/dmm.030403 · 2017 · External reference

Ex vivo testing of patient-derived xenografts mirrors the clinical outcome of patients with pancreatic ductal adenocarcinoma.

10.1158/1078-0432.ccr-15-2936 · 2016 · External reference

Development of Patient-Derived Preclinical Platform for Metastatic Pancreatic Cancer: PDOX and a Subsequent Organoid Model System Using Percutaneous Biopsy Samples.

10.3389/fonc.2019.00875 · 2019 · External reference

Preparation and incubation of precision-cut liver and intestinal slices for application in drug metabolism and toxicity studies.

10.1038/nprot.2010.111 · 2010 · External reference

High-Content Biopsies Facilitate Molecular Analyses and Do Not Increase Complication Rates in Patients With Advanced Solid Tumors.

10.1200/po.17.00081 · 2017 · External reference

Use of Precision-Cut Lung Slices as an Ex Vivo Tool for Evaluating Viruses and Viral Vectors for Gene and Oncolytic Therapy.

10.1016/j.omtm.2018.07.010 · 2018 · External reference

Precision-cut human liver slice cultures as an immunological platform.

10.1016/j.jim.2018.01.012 · 2018 · External reference

Tumor Organoids as a Pre-clinical Cancer Model for Drug Discovery.

10.1016/j.chembiol.2017.06.012 · 2017 · External reference

Temperature variations within and between incubators-a prospective, observational study.

10.1007/s10815-013-0104-0 · 2013 · External reference

Oxygenation in cell culture: Critical parameters for reproducibility are routinely not reported.

10.1371/journal.pone.0204269 · 2018 · External reference

Limitations of oxygen delivery to cells in culture: An underappreciated problem in basic and translational research.

10.1016/j.freeradbiomed.2017.10.003 · 2017 · External reference

WEBINAR: What is hyperoxia, normoxia and hypoxia to cells: Why researchers should care about environmental oxygen and how it influences results

External reference

A microfluidics platform for combinatorial drug screening on cancer biopsies.

10.1038/s41467-018-04919-w · 2018 · External reference

Microfluidics as an Enabling Technology for Personalized Cancer Therapy.

10.1002/smll.201904321 · 2020 · External reference

Maintenance of head and neck tumor on-chip: Gateway to personalized treatment?

10.4155/fsoa-2016-0089 · 2017 · External reference

Development of a Microfluidic Culture Paradigm for Ex Vivo Maintenance of Human Glioblastoma Tissue: A New Glioblastoma Model?

10.1016/j.tranon.2019.09.002 · 2020 · External reference

Innovative organotypic in vitro models for safety assessment: aligning with regulatory requirements and understanding models of the heart, skin, and liver as paradigms.

10.1007/s00204-018-2152-9 · 2018 · External reference

Materials for Microfluidic Chip Fabrication.

10.1021/ar300314s · 2013 · External reference

High-Performance Materials for 3D Printing in Chemical Synthesis Applications.

10.1002/adma.201805982 · 2019 · External reference

Design of Sealable Custom-Shaped Cell Mimicries Based on Self-Assembled Monolayers on CYTOP Polymer.

10.1021/acsami.9b05073 · 2019 · External reference

PDMS-based microfluidic devices for cell culture.

10.3390/inventions3030065 · 2018 · External reference

Advantages and challenges of microfluidic cell culture in polydimethylsiloxane devices.

10.1016/j.bios.2014.07.029 · 2015 · External reference

Vanderbilt researchers win an R&D100 Award for MultiWell MicroFormulator.

External reference

NCATS Supports Award-Winning Technology for Drug Development.

External reference

A 96-well microplate bioreactor platform supporting individual dual perfusion and high-throughput assessment of simple or biofabricated 3D tissue models.

10.1039/c8lc00485d · 2018 · External reference

Methods of delivering mechanical stimuli to Organ-on-a-Chip.

10.3390/mi10100700 · 2019 · External reference

Multi-organs-on-chips: Towards long-term biomedical investigations.

10.3390/molecules24040675 · 2019 · External reference

A standalone perfusion platform for drug testing and target validation in micro-vessel networks.

10.1063/1.4818837 · 2013 · External reference

Democratising Technology: the Confluence of Makers and Grassroot Innovators.

2015 · External reference

Technological Sovereignty: Democratising Technology and Innovation [green paper]. Progressive Agenda for Europe

2019 · External reference

Moving beyond the Three Rs in Biomedical Research.

External reference

ARRIVE guidelines.

External reference

The National Institutes of Health Microphysiological Systems Program focuses on a critical challenge in the drug discovery pipeline.

10.1186/scrt361 · 2013 · External reference

3S - Systematic, systemic, and systems biology and toxicology.

10.14573/altex.1804051 · 2018 · External reference

Ban on animal testing.

External reference

human Organ and Disease Model Technologies.

External reference

Organ on Chip in Development.

External reference

EUROoC.

External reference

Bad Witches: Gender and the downfall of Elizabeth Holmes of Theranos and Disney’s Maleficent.

10.3390/socsci8060175 · 2019 · External reference

EURL ECVAM Status Report on the Development, Validation and Regulatory Acceptance of Alternative Methods and Apporaches.

2018 · External reference

Applications of CRISPR technologies in research and beyond.

10.1038/nbt.3659 · 2016 · External reference

Beyond CRISPR: What’s current and upcoming in genome editing.

External reference

The commercialization of genome-editing technologies.

10.1080/07388551.2016.1271768 · 2017 · External reference

30 years of microfluidics.

10.1016/j.mne.2019.01.003 · 2019 · External reference

Microfluidics for genome-wide studies involving next generation sequencing.

10.1063/1.4978426 · 2017 · External reference

Small but Perfectly Formed? Successes, Challenges, and Opportunities for Microfluidics in the Chemical and Biological Sciences.

10.1016/j.chempr.2017.01.009 · 2017 · External reference

Rwanda is Building Africa’s Very Own Silicon Valley – Kigali Innovation City (KIC).

External reference

Rwanda is bringing tech buzz to Africa.

External reference

Africa's first 'Silicon Valley' to be built in Rwanda.

External reference

Human Genomics Research Has A Diversity Problem.

External reference

Diversity and inclusion in genomic research: why the uneven progress?

10.1007/s12687-017-0316-6 · 2017 · External reference

Building the future of health research: Proposal for a European Council for Health Research.

2018 · External reference

A New Pharmaceutical Commons: Transforming Drug Discovery.

External reference

Latest global cancer data: Cancer burden rises to 19.3 million new cases and 10.0 million cancer deaths in 2020.

External reference

Global Cancer Statistics 2018: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.

10.3322/caac.21492 · 2018 · External reference

Cancer Surpasses CVD as Leading Cause of Death in High-Income Counties.

External reference

Cancer Overtakes CVD as Leading Cause of Death in Wealthy Nations.

External reference

Cancer Therapeutics Market by Application (Blood Cancer, Lung Cancer, Colorectal Cancer, Prostate Cancer, Breast Cancer, Cervical Cancer, Head & Neck Cancer, Glioblastoma, Malignant Meningioma, Mesothelioma, Melanoma, and Others) and Top Selling Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Velcade, Imbruvica, Ibrance, Zytiga, Alimta, Xtandi, Tarceva, Perjeta, Temodar, and Others): Global Opportunity Analysis and Industry Forecast, 2019 – 2026.

External reference

Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions.

External reference

Global Cancer Therapeutics Market: Emphasis on Recurrent and Metastatic Divisions.

External reference

Global Cancer Therapeutics Market Size By Application, By End User, By Geographic Scope and Forecast.

External reference

Cancer Diagnostics Market Worth $249.6 Billion By 2026 CAGR: 7.0%.

External reference

Cancer Diagnostics Market by Technology (ELISA, ELFA, PCR, NGS, Immunohistochemistry, Microarray, Imaging (MRI, CT, PET, Ultrasound, Mammography), Biopsy), Application (Breast Cancer, Lung Cancer, Colorectal Cancer, Melanoma) - Forecast to 2020.

External reference

Cancer Diagnostics Market - Growth, Trends, and Forecasts (2020 - 2025).

External reference

Cancer Diagnostics Market Size By Application (Tumor Biomarkers Tests, Imaging {Ultrasound and Radiology, Mammography, MRI Scan, PET Scan, CT Scan, SPECT & Others}, Biopsy, Liquid Biopsy, Immunohistochemistry, In Situ Hybridization), By Cancer Type (Bladder Cancer, Breast Cancer, Colon and Rectal Cancer, Endometrial Cancer, Kidney Cancer, Leukemia, Liver-Lung Cancer, Melanoma, Non-Hodgkin Lymphoma, Pancreatic Cancer, Prostate Cancer, Thyroid Cancer), By End-use (Hospitals, Diagnostic Laboratories, Diagnostic Imaging Centers, Cancer Research Institutes), Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2020 – 2026.

External reference

Global Personalized Medicine Market – Types, Technologies and Applications.

External reference

Personalized Medicine, Targeted Therapeutics and Companion Diagnostic Market to 2025 - Strategic Analysis of Industry Trends, Technologies, Participants, and Environment.

External reference

Companion Diagnostics - Global Market Trajectory & Analytics.

External reference

A marriage of tumor slices and microfluidics.

External reference

A microfluidic device for exposing tumor biopsy tissue to multiple drugs.

2012 · External reference

Parallel microfluidic chemosensitivity testing on individual slice cultures.

10.1039/c4lc00642a · 2014 · External reference

Microfluidic transwell inserts for generation of tissue culture-friendly gradients in well plates.

10.1039/c3lc51052b · 2014 · External reference

BaroFuse, a novel pressure-driven, adjustable-throughput perfusion system for tissue maintenance and assessment.

10.1016/j.heliyon.2016.e00210 · 2016 · External reference

Microfluidic assay apparatus and methods of use

2014 · External reference

OncoFluidics

External reference

Plant-based and Cultured Meat 2020-2030.

External reference

Organ-on-A-chip devices advance to market.

10.1039/c6lc01554a · 2017 · External reference

Hybrid business models for ‘Organ-on-a-Chip’ technology: The best of both worlds.

10.1016/j.phanu.2018.02.001 · 2018 · External reference

Organovo

External reference

Organovo exploring strategic alternatives and implementing restructuring plan

External reference

Organovo Holdings

External reference

Organovo & Merck Enter Multi-year Research Partnership for 3D Printed Human Tissue

External reference

L'Oreal's Plan to Start 3D Printing Human Skin

External reference

Media Coverage

External reference

Organovo Files Definitive Proxy Statement and Sends Letter to Stockholders

External reference

Organovo Announces Termination of Merger Agreement with Tarveda Therapeutics

External reference

Interoperability of microfluidic devices — Guidelines for pitch spacing dimensions and initial device classification

External reference

AIM Biotech

External reference

Products

External reference

Microfluidic platform for investigating cell-based interactions

2016 · External reference

3D Cell Culture Chip

External reference

AIM Biotech Overview

External reference

AIM Biotech 3D Organ-On-A-Chip Devices

External reference

ibidi at a Glance

External reference

New Market Reports

External reference

Live Cell Imaging Market to Reach USD 3.76 Billion By 2026

External reference

Live Cell Imaging Market - Growth, Trends, and Forecasts (2020 - 2025)

External reference

Live Cell Imaging Market worth $2.9 billion by 2023

External reference

World Live Cell Imaging Market - Opportunities and Forecast, 2020-2027

External reference

ISO 9000 Family

External reference

ISO 13485

External reference

Grants Awarded

External reference

CellASIC Corp

External reference

Synthetic control of mammalian-cell motility by engineering chemotaxis to an orthogonal bioinert chemical signal.

10.1073/pnas.1402087111 · 2014 · External reference

Arginine starvation-associated atypical cellular death involves mitochondrial dysfunction, nuclear DNA leakage, and chromatin autophagy.

10.1073/pnas.1404171111 · 2014 · External reference

NF-κB oscillations translate into functionally related patterns of gene expression.

10.7554/elife.09100 · 2016 · External reference

Applications of the CellASIC® ONIX Microfluidic Platform

External reference

Tutorials/Protocols for the CellASIC® ONIX Microfluidic Platform

External reference

CellASIC® ONIX Live Cell Analysis Customer Reviews

External reference

FDA signs collaborative agreement with CN Bio Innovations to use Organs-on-Chips to improve drug development and evaluation

External reference

CN Bio Innovations announces research collaboration with AstraZeneca to validate a new in vitro tool to predict optimised drug dosing regimens for multi-drug therapies

2020 · External reference

CN Bio Innovations announces license of worldwide rights to Hepatitis B programme from Bristol-Myers Squibb.

External reference

CN Bio Innovations announces licence of platform microfluidics technologies from Vanderbilt University.

External reference

PhysioMimix™ Human 3D Cell Culture wins Lab Innovation 2018 Award

External reference

Characterizing the Reproducibility in Using a Liver Microphysiological System for Assaying Drug Toxicity, Metabolism and Accumulation.

10.1111/cts.12969 · 2020 · External reference

Design, modeling and fabrication of a constant flow pneumatic micropump.

10.1088/0960-1317/17/5/007 · 2007 · External reference

Perfused multiwell plate for 3D liver tissue engineering.

10.1039/b913221j · 2010 · External reference

Bioreactor technologies to support liver function in vitro.

10.1016/j.addr.2014.02.011 · 2014 · External reference

Metabolite profiling and pharmacokinetic evaluation of hydrocortisone in a perfused three-dimensional human liver bioreactor.

10.1124/dmd.115.063495 · 2015 · External reference

Modeling therapeutic antibody-small molecule drug-drug interactions using a three-dimensional perfusable human liver coculture platform.

10.1124/dmd.116.071456 · 2016 · External reference

Three-dimensional perfused human in vitro model of non-alcoholic fatty liver disease.

10.3748/wjg.v23.i2.204 · 2017 · External reference

Integrated assessment of diclofenac biotransformation, pharmacokinetics, and omics-based toxicity in a three-dimensional human liver-immunocompetent coculture systems.

10.1124/dmd.116.074005 · 2017 · External reference

Quantitative assessment of population variability in hepatic drug metabolism using a perfused three-dimensional human liver microphysiological system.

10.1124/jpet.116.237495 · 2017 · External reference

3D microfluidic liver cultures as a physiological preclinical tool for hepatitis B virus infection.

10.1038/s41467-018-02969-8 · 2018 · External reference

A Microphysiological System for Studying Nonalcoholic Steatohepatitis.

10.1002/hep4.1450 · 2019 · External reference

Quantitative Systems Pharmacology Approaches Applied to Microphysiological Systems (MPS): Data Interpretation and Multi-MPS Integration.

10.1002/psp4.12010 · 2015 · External reference

Integrated Gut and Liver Microphysiological Systems for Quantitative In Vitro Pharmacokinetic Studies.

10.1208/s12248-017-0122-4 · 2017 · External reference

Establishing quasi-steady state operations of microphysiological systems (MPS) using tissue-specific metabolic dependencies.

10.1038/s41598-018-25971-y · 2018 · External reference

CN Bio Innovations raises $9 million USD (c. £6.9 million GBP).

External reference

CN Bio Innovations raises $9 million USD (c. £6.9 million GBP).

External reference

Women In Innovation: Developing 'Organs-On-Chips'.

External reference

BBC World Service.

External reference

Liver on a Chip.

External reference

Discovery Channel, Developmental Biology.

External reference

About Us.

External reference

Emulate.

External reference

Donald Ingber.

External reference

Reconstituting Organ-Level Lung Functions on a Chip.

10.1126/science.1188302 · 2010 · External reference

Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment.

10.1039/c3ib40049b · 2013 · External reference

Bone-chip system to monitor osteogenic differentiation using optical imaging.

10.1007/s10404-019-2261-7 · 2019 · External reference

Bone marrow-on-a-chip replicates hematopoietic niche physiology in vitro.

10.1038/nmeth.2938 · 2014 · External reference

Microfabrication of human organs-on-chips.

10.1038/nprot.2013.137 · 2013 · External reference

Human gut-on-a-chip inhabited by microbial flora that experiences intestinal peristalsis-like motions and flow.

10.1039/c2lc40074j · 2012 · External reference

Enhanced Utilization of Induced Pluripotent Stem Cell-Derived Human Intestinal Organoids Using Microengineered Chips.

10.1016/j.jcmgh.2017.12.008 · 2017 · External reference

Human gut-on-a-chip supports polarized infection of coxsackie B1 virus in vitro.

10.1371/journal.pone.0169412 · 2017 · External reference

Assessment of whole blood thrombosis in a microfluidic device lined by fixed human endothelium.

10.1007/s10544-016-0095-6 · 2016 · External reference

Primary Human Lung Alveolus-on-a-chip Model of Intravascular Thrombosis for Assessment of Therapeutics.

10.1002/cpt.742 · 2018 · External reference

A human disease model of drug toxicity-induced pulmonary edema in a lung-on-a-chip microdevice.

10.1126/scitranslmed.3004249 · 2012 · External reference

Small airway-on-a-chip enables analysis of human lung inflammation and drug responses in vitro.

10.1038/nmeth.3697 · 2016 · External reference

Optimizing drug discovery by investigative toxicology: Current and future trends.

10.14573/altex.1808181 · 2019 · External reference

Application of Microphysiological Systems to Enhance Safety Assessment in Drug Discovery.

10.1146/annurev-pharmtox-010617-052722 · 2018 · External reference

Emulate, Inc. and INTENZE Products, Inc. Announce Collaboration to Use Organ-Chips to Study Tattoo Ink Safety Risks.

External reference

FDA to Use Emulate's Organ-on-a-Chip Technology for Toxicology Testing.

External reference

FDA Signs Collaborative Agreement with Emulate, Inc. to Use Organs-on-Chips Technology as a Toxicology Testing Platform for Understanding How Products Affect Human Health and Safety.

External reference

Miniature liver on a chip could boost US food safety.

External reference

Emulate Announces Strategic Collaboration with Johnson & Johnson Innovation to Use Organs-on-Chips Platform to Better Predict Human Response in Drug Development Process.

External reference

New Data from Emulate’s Asthma-on-Chip Presented at American Thoracic Society Annual Meeting.

External reference

Emulate Announces Expanded Collaboration with Merck to Use Organ-Chips in Drug Discovery and Development Process for Inflammatory Diseases.

External reference

Emulate, Inc. Awarded Michael J. Fox Foundation Grant to use Organs-on-Chips to Investigate Drug Candidates for Treatment of Parkinson’s Disease.

External reference

SpaceX Dragon Heads to Space Station with NASA Science, Cargo.

External reference

Emulate, Inc. Appoints Jim Corbett as Chief Executive Officer and Martin Madaus, PhD, as Executive Chairman.

External reference

The Design and Fabrication of Three-Chamber Microscale Cell Culture Analog Devices with Integrated Dissolved Oxygen Sensors.

10.1021/bp034077d · 2004 · External reference

Incorporation of 3T3-L1 cells to mimic bioaccumulation in a microscale cell culture analog device for toxicity studies.

10.1021/bp034238d · 2004 · External reference

Hurel.

External reference

A dynamic in vivo surrogate assay platform for cell-based studies.

2004 · External reference

Hurel.

External reference

Which models to use in Early Toxicology Assessment to detect Human Hepatotoxic Drugs?

External reference

Long-term hepatitis B infection in a scalable hepatic co-culture system.

10.1038/s41467-017-00200-8 · 2017 · External reference

Persistent hepatitis B viral infection in a novel, scalable primary hepatocyte co-culture system.

2017 · External reference

Development of a Microscale Cell Culture Analog to Probe Naphthalene Toxicity.

10.1021/bp0341996 · 2004 · External reference

Real-time fluorescence detection of multiple microscale cell culture analog devices in situ.

10.1002/cyto.a.20427 · 2007 · External reference

Oxygen-mediated enhancement of primary hepatocyte metabolism, functional polarization, gene expression, and drug clearance.

10.1073/pnas.0906820106 · 2009 · External reference

Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human.

10.1016/j.bcp.2009.05.013 · 2009 · External reference

A novel system for evaluation of drug mixtures for potential efficacy in treating multidrug resistant cancers.

10.1002/bit.22219 · 2009 · External reference

A microfluidic hepatic coculture platform for cell-based drug metabolism studies.

10.1016/j.bcp.2009.11.010 · 2010 · External reference

Assessment of a Micropatterned Hepatocyte Coculture System to Generate Major Human Excretory and Circulating Drug Metabolites.

10.1124/dmd.110.034876 · 2010 · External reference

Evaluation of the relevance of DILI predictive hypotheses in early drug development: Review of In vitro methodologies vs BDDCS classification.

10.1039/c8tx00016f · 2018 · External reference

Determination of human hepatocyte intrinsic clearance for slowly metabolized compounds: Comparison of a primary hepatocyte/stromal cell co-culture with plated primary hepatocytes and hepaRG.

10.1124/dmd.115.067769 · 2016 · External reference

Hurel Corporation And Johnson and Johnson Pharmaceutical R&D Enter Into Joint Scientific Collaboration.

External reference

J&JPRD and Hurel enter scientific collaboration.

External reference

Products.

External reference

ACEA Biosciences and Hurel Corporation Announce Joint Marketing of Integrated Product Kits.

External reference

Hurel announces partnership with Cyprotex.

External reference

Optivia Biotechnology Forms Technology and Marketing Alliance with Hurel Corporation.

External reference

Hurel and Sanofi enter cell-based R&D Collaboration.

External reference

HµREL humanPool: Combining the phenotypic breadth of pooled primary hepatocytes with the stable, long-enduring cellular competency of HµREL co-culture technology.

External reference

HUB Organoids.

External reference

Multi-tissue interactions in an integrated three-tissue organ-on-a-chip platform.

10.1038/s41598-017-08879-x · 2017 · External reference

Development of a 3D tissue slice culture model for the study of human endometrial repair and regeneration.

10.3390/biom10010136 · 2020 · External reference

3D microfluidic Ex vivo culture of organotypic tumor spheroids to model immune checkpoint blockade.

10.1039/c8lc00322j · 2018 · External reference

Patient-derived organoid models help define personalized management of gastrointestinal cancer.

10.1002/bjs.10726 · 2018 · External reference

Method of preparing cells for 3D tissue culture.

2015 · External reference

Hanging drop plate.

2010 · External reference

A High-Throughput-Compatible 3D Microtissue Co-Culture System for Phenotypic RNAi Screening Applications.

10.1177/1087057113499071 · 2013 · External reference

Development of an Innovative 3D Cell Culture System to Study Tumour--Stroma Interactions in Non-Small Cell Lung Cancer Cells.

10.1371/journal.pone.0092511 · 2014 · External reference

The importance of inter-individual Kupffer cell variability in the governance of hepatic toxicity in a 3D primary human liver microtissue model.

10.1038/s41598-019-43870-8 · 2019 · External reference

Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype.

2019 · External reference

InSphero Announces Collaboration with NIH National Center for Advancing Translational Sciences (NCATS).

External reference

NIH/NCATS and InSphero Host Inaugural 3D Tumor Model Standards Working Group at AACR 2017.

External reference

Comprehensive Study by AstraZeneca and Genentech Confirms Superiority of InSphero Human Liver Microtissues for Prediction of Drug-Induced Liver Injury.

External reference

InSphero’s CEO Jan Lichtenberg wins Entrepreneur Of The Year™ 2015.

External reference

InSphero Scientist Receives 3Rs ward for Microtissue-based Body on a Chip System.

External reference

Protea Biosciences and InSphero AG Enter into Collaboration and Co-marketing Agreement to Combine 3D Technologies.

External reference

InSphero Partners with ALPCO to Advance Diabetes Research.

External reference

InSphero Receives Additional USD 10m for Organ-on-a-Chip Disease Models.

External reference

InSphero Announces Agreement with Pfizer to Develop Novel Assays for Predicting Drug-induced Liver Injury.

External reference

AstraZeneca Relies on 3D Insight™ Human Islet Microtissues in Pancreatic Beta-cell Study.

External reference

InSphero Certified for ISO 9001:2015.

External reference

Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury.

10.1007/s00204-017-2002-1 · 2017 · External reference

Transcriptomic, Proteomic, and Functional Long-Term Characterization of Multicellular Three-Dimensional Human Liver Microtissues.

10.1089/aivt.2017.0022 · 2018 · External reference

Evaluation of assays for drug efficacy in a three-dimensional model of the lung.

10.1007/s00432-016-2198-0 · 2016 · External reference

Adding the 'heart’ to hanging drop networks for microphysiological multi-tissue experiments.

10.1039/c5lc01000d · 2015 · External reference

Functional coupling of human pancreatic islets and liver spheroids on-a-chip: Towards a novel human ex vivo type 2 diabetes model.

10.1038/s41598-017-14815-w · 2017 · External reference

Microphysiological Systems: Engineered for Biological InSIght.

External reference

Phaseguides: A paradigm shift in microfluidic priming and emptying.

10.1039/c0lc00643b · 2011 · External reference

Phaseguide patterns for liquid manipulation.

2010 · External reference

Phaseguide patterns for liquid manipulation.

2011 · External reference

1.6 million USD pharma funding for kidney-on-a-chip nephrotoxicity model.

External reference

Pharma-supported pilot towards neurotox model.

External reference

MIMETAS and Galapagos to develop human disease models on-a-chip.

External reference

In Nature Communications: gut-on-a-chip in high throughput leak-tight intestinal tubules to study toxicology, transport, and disease.

External reference

Molecular Devices and MIMETAS sign co-marketing agreement.

External reference

Barrier function measurements.

2017 · External reference

Development of a gut-on-a-chip model for high throughput disease modeling and drug discovery.

10.3390/ijms20225661 · 2019 · External reference

Meet us.

External reference

MIMETAS And Hubrecht Organoid Technologies Partner To Market Organoids-On-A-Chip.

External reference

Snake Venom Gland Organoids.

10.1016/j.cell.2019.11.038 · 2020 · External reference

A glomerulus-on-a-chip to recapitulate the human glomerular filtration barrier.

10.1038/s41467-019-11577-z · 2019 · External reference

Membrane-free culture and real-time barrier integrity assessment of perfused intestinal epithelium tubes.

10.1038/s41467-017-00259-3 · 2017 · External reference

Screening of Drug-Transporter Interactions in a 3D Microfluidic Renal Proximal Tubule on a Chip.

10.1208/s12248-018-0247-0 · 2018 · External reference

Combining Extracellular miRNA Determination with Microfluidic 3D Cell Cultures for the Assessment of Nephrotoxicity: a Proof of Concept Study.

10.1208/s12248-018-0245-2 · 2018 · External reference

Flow stimulates drug transport in a human kidney proximal tubule-on-a-chip independent of primary cilia.

10.1016/j.bbagen.2019.129433 · 2020 · External reference

Nephrotoxicity and Kidney Transport Assessment on 3D Perfused Proximal Tubules.

10.1208/s12248-018-0248-z · 2018 · External reference

On-chip three-dimensional cell culture in phaseguides improves hepatocyte functions in vitro.

10.1063/1.4922863 · 2015 · External reference

3D Cultures of Parkinson’s Disease-Specific Dopaminergic Neurons for High Content Phenotyping and Drug Testing.

10.1002/advs.201800927 · 2018 · External reference

High-throughput compound evaluation on 3D networks of neurons and glia in a microfluidic platform.

10.1038/srep38856 · 2016 · External reference

Three-dimensional (3D) tetra-culture brain on chip platform for organophosphate toxicity screening.

10.1038/s41598-018-20876-2 · 2018 · External reference

A perfused human blood-brain barrier on-a-chip for high-throughput assessment of barrier function and antibody transport.

10.1186/s12987-018-0108-3 · 2018 · External reference

3D human microvessel-on-a-chip model for studying monocyte-to-endothelium adhesion under flow - application in systems toxicology.

10.14573/altex.1811301 · 2020 · External reference

Acoustic Characterization of a Vessel-on-a-Chip Microfluidic System for Ultrasound-Mediated Drug Delivery.

10.1109/tuffc.2018.2803137 · 2018 · External reference

96 perfusable blood vessels to study vascular permeability in vitro.

10.1038/s41598-017-14716-y · 2017 · External reference

Therapy response testing of breast cancer in a 3D high-throughput perfused microfluidic platform.

10.1186/s12885-017-3709-3 · 2017 · External reference

Interstitial flow recapitulates gemcitabine chemoresistance in a 3D microfluidic pancreatic ductal adenocarcinoma model by induction of multidrug resistance proteins.

10.3390/ijms20184647 · 2019 · External reference

MIMETAS Opens New Laboratory Facilities and Offices in the USA.

External reference

Jos Joore: "Personalized Medicine - Going for the Sure Cure" | TEDxBinnenhof 2016.

External reference

Channeling chip power: Tissue chips are being put to the test by industry.

10.1038/nm0217-138 · 2017 · External reference

OrganoPlate®.

External reference

MIMETAS: High-throughput 3D perfused tissue models.

External reference

Y and Z Generations at Workplaces.

10.7441/joc.2016.03.06 · 2016 · External reference

Generational differences in workplace behavior.

10.1111/jasp.12208 · 2014 · External reference

Different Generations’ Attitudes Towards Work and Management in the Business Organizations.

2017 · External reference

Pioneer Advantage: Marketing Logic or Marketing Legend?

10.2307/3172825 · 1993 · External reference

First-mover advantages from pioneering new markets: A Survey of Empirical Evidence.

10.1007/bf01024216 · 1994 · External reference

Pioneer-Migrator-Settler (PMS) Map.

External reference

Excavating The Video-Game Industry’s Past.

External reference

Down Many Times, but Still Playing the Game.

2006 · External reference

Company Information.

External reference

What is search engine optimization: SEO?

10.1016/j.sbspro.2010.12.185 · 2010 · External reference

Understanding Search-Engine Optimization.

10.1109/mc.2015.297 · 2015 · External reference

External Communication Strategy 2020.

External reference

Communication tips for ERC grantees.

External reference

Social Media & Outreach.

External reference

Use of social media to enhance the impact of published papers.

2018 · External reference

Announcing PETA’s 2014 Company of the Year.

External reference

Hurel Wins Proggy for Groundbreaking Non-Animal Testing Method.

External reference

Hurel Receives Funding From The Humane Society.

External reference

Evolution of coopetition in a cluster: the case of Waipara in the wine sector.

10.1080/08276331.2013.822144 · 2013 · External reference

Expanding the networks of disadvantaged entrepreneurs.

2015 · External reference

Hepatocellular Carcinoma.

10.15586/hepatocellularcarcinoma.2019 · 2019 · External reference

Comprehensive Evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury.

10.3389/fphar.2019.01093 · 2019 · External reference

Theranos Case Study: What Went Wrong?

2019 · External reference

The Theranos saga and the consequences.

10.1515/cclm-2018-0392 · 2018 · External reference

SEC v Holmes et al. [legal document].

External reference

5 Top Emerging Organ-on-a-Chip (OOC) Startups Impacting The Pharma Sector.

External reference

Global Cell Therapy Technologies Market 2021 Size, Development Status, Type and Application, Segmentation, Forecast 2030.

External reference